David Eansor's Insider Trades & SAST Disclosures
David Eansor's most recent trade in Marker Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Eansor.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 12 Nov 2021 | 27,159 | 28,477 (0%) | 0% | 125.1 | 3,396,233 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 27,159 | 799 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 503.61 per share. | 12 Nov 2021 | 9,043 | 13,243 (0%) | 0% | 503.6 | 4,554,137 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.39 per share. | 12 Nov 2021 | 8,989 | 4,254 (0%) | 0% | 504.4 | 4,533,985 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 502.77 per share. | 12 Nov 2021 | 4,054 | 22,286 (0%) | 0% | 502.8 | 2,038,221 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 505.49 per share. | 12 Nov 2021 | 2,535 | 1,719 (0%) | 0% | 505.5 | 1,281,407 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 799 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 12 Nov 2021 | 799 | 2,117 (0%) | 0% | 125.1 | 99,915 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.09 per share. | 12 Nov 2021 | 700 | 27,777 (0%) | 0% | 504.1 | 352,860 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.14 per share. | 12 Nov 2021 | 537 | 26,740 (0%) | 0% | 504.1 | 270,725 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 506.24 per share. | 12 Nov 2021 | 401 | 1,318 (0%) | 0% | 506.2 | 203,002 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 505.00 per share. | 12 Nov 2021 | 400 | 26,340 (0%) | 0% | 505.0 | 202,002 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 502.99 per share. | 12 Nov 2021 | 300 | 27,277 (0%) | 0% | 503.0 | 150,897 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.78 per share. | 12 Nov 2021 | 200 | 27,577 (0%) | 0% | 504.8 | 100,956 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 503.07 per share. | 31 Aug 2021 | 1,538 | 1,318 (0%) | 0% | 503.1 | 773,728 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 8,107 | 8,107 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 6,080 | 6,080 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 2,537 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 2,537 | 3,855 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 1,556 | 1,556 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 481.82 per share. | 06 Aug 2021 | 999 | 2,856 (0%) | 0% | 481.8 | 481,338 | Common Stock |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 12,658 | 36,940 (0%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | N. David Eansor | Director | Purchase of securities on an exchange or from another person at price $ 17.50 per share. | 16 Mar 2021 | 14,285 | 16,713 (0%) | 0% | 17.5 | 249,988 | Common Stock |
| Marker Therapeutics Inc | N. David Eansor | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Mar 2021 | 14,285 | 2,428 (0%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Marker Therapeutics Inc | N. David Eansor | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Mar 2021 | 7,142 | 7,142 (0%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | N. David Eansor | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Mar 2021 | 7,142 | 7,142 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 05 Feb 2021 | 18,819 | 34,251 (0%) | 0% | 106.6 | 2,005,917 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 18,819 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,114 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 05 Feb 2021 | 14,114 | 15,432 (0%) | 0% | 106.6 | 1,504,411 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 380.50 per share. | 05 Feb 2021 | 12,833 | 10,918 (0%) | 0% | 380.5 | 4,882,918 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 378.29 per share. | 05 Feb 2021 | 6,000 | 28,251 (0%) | 0% | 378.3 | 2,269,723 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 379.62 per share. | 05 Feb 2021 | 4,500 | 23,751 (0%) | 0% | 379.6 | 1,708,312 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 382.60 per share. | 05 Feb 2021 | 3,700 | 4,318 (0%) | 0% | 382.6 | 1,415,636 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 381.52 per share. | 05 Feb 2021 | 2,900 | 8,018 (0%) | 0% | 381.5 | 1,106,395 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 384.15 per share. | 05 Feb 2021 | 1,900 | 2,418 (0%) | 0% | 384.2 | 729,888 | Common Stock |
| Bio-Techne Corp | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 385.59 per share. | 05 Feb 2021 | 1,100 | 1,318 (0%) | 0% | 385.6 | 424,151 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2020 | 2,174 | 2,174 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2020 | 2,174 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 265.76 per share. | 09 Aug 2020 | 856 | 1,318 (0%) | 0% | 265.8 | 227,491 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 24,975 | 24,975 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 24,975 | 24,975 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 15,318 | 15,318 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 11,488 | 11,488 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 2,575 | 2,575 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 7,909 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 28 May 2020 | 7,909 | 7,909 (0%) | 0% | 108.5 | 858,047 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 3,448 | 7,909 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 260.19 per share. | 28 May 2020 | 3,448 | 0 (0%) | 0% | 260.2 | 897,134 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 28 May 2020 | 3,448 | 3,448 (0%) | 0% | 108.5 | 374,074 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 261.74 per share. | 28 May 2020 | 3,400 | 2,809 (0%) | 0% | 261.7 | 889,927 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 262.68 per share. | 28 May 2020 | 2,100 | 709 (0%) | 0% | 262.7 | 551,619 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 260.83 per share. | 28 May 2020 | 1,700 | 6,209 (0%) | 0% | 260.8 | 443,410 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 264.01 per share. | 28 May 2020 | 709 | 0 (0%) | 0% | 264.0 | 187,184 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.35 per share. | 21 May 2020 | 11,037 | 11,037 (0%) | 0% | 94.4 | 1,041,341 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2020 | 11,037 | 3,963 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 267.37 per share. | 21 May 2020 | 10,137 | 900 (0%) | 0% | 267.4 | 2,710,320 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2020 | 8,637 | 11,357 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 21 May 2020 | 8,637 | 12,600 (0%) | 0% | 108.5 | 937,028 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 267.63 per share. | 21 May 2020 | 7,676 | 4,924 (0%) | 0% | 267.6 | 2,054,290 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 268.41 per share. | 21 May 2020 | 4,924 | 0 (0%) | 0% | 268.4 | 1,321,636 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.35 per share. | 21 May 2020 | 3,963 | 3,963 (0%) | 0% | 94.3 | 373,909 | Common Stock |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2020 | 3,963 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 268.89 per share. | 21 May 2020 | 900 | 0 (0%) | 0% | 268.9 | 241,997 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges